Race-based drug
A drug designed for a particular racial group.
The first race-based drug was BiDil, a combination of two old drugs that increase levels of nitric oxide.
BiDil was tested in African-Americans and reported in 2004 to reduce deaths from heart disease.
The very concept of race-based therapy is highly controversial.
While some black cardiologists hailed BiDil, others have seen it as nothing but a marketing ploy, using race rather than science to tailor therapies